LATINA Style Inc. Recognizes Kaiser Permanente and Dr. Cynthia Telles in the 2019 LATINA Style 50 Report
LOS ANGELES, CA / ACCESSWIRE / November 19, 2019 / Empowering Latinas - one woman at a time. LATINA Style,...
Staff
Aytu BioScience Announces Addition of Tuzistra(R) XR to Leading Pharmacy Benefit Manager’s National Formulary
Provides More Than Six Million US Lives Unrestricted Access to Only FDA-Approved 12-Hour Codeine-Based Cold-Cough Syrup ENGLEWOOD, CO / ACCESSWIRE...
Emergent Health Corp. (OTC PINK:EMGE) Announces New Evidence That Chronic Kidney Disease and Renal Dialysis Time May Be Reduced or Reversed
KING OF PRUSSIA, PA / ACCESSWIRE / November 19, 2019 / Chronic Kidney Disease (CKD) is a world-wide affliction. Many...
Clinical Innovations hires Rebecca Liu as VP, general manager for CI Medical Instruments in China
Experienced executive will accelerate company’s growth in quickly developing market SALT LAKE CITY--(BUSINESS WIRE)--Clinical Innovations, one of the world’s largest...
The NDP Government’s Proposed Denturist Regulations Put Seniors at Risk
NANAIMO, BC / ACCESSWIRE / November 18, 2019 / The Denturist Association of BC (DABC) is demanding that the government...
InterVenn Biosciences Announces Positive Interim Clinical Trial Results and Appoints Biotech Veteran Klaus Lindpaintner, M.D. as Chief Scientific and Medical Officer
REDWOOD CITY, Calif.--(BUSINESS WIRE)--InterVenn Biosciences, a company in the life sciences and technology sector, is pleased to announce that the...
Kadmon Announces Closing of $101.6mm Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
NEW YORK, NY / ACCESSWIRE / November 18, 2019 / Kadmon Holdings, Inc. (NYSE:KDMN) today announced the closing of its...
Intellipharmaceutics Closes USD$250,000 Convertible Debenture Financing with Drs. Isa and Amina Odidi
TORONTO, ON / ACCESSWIRE / November 18, 2019 / Intellipharmaceutics International Inc. (OTCQB:IPCIF and TSX:IPCI) ("Intellipharmaceutics" or the "Company") and...
InnoCan Signs Agreement to Manufacture Products in the U.S.
HERZELIYA, ISRAEL and CALGARY, ALBERTA / ACCESSWIRE / November 18, 2019 / InnoCan Pharma Corporation ("InnoCan" or the "Company") (CSE:INNO)...
The Medical Alley Association and Accenture Collaborate to Lead the Healthcare Transformation Initiative
MINNEAPOLIS--(BUSINESS WIRE)--#Healthcare--In a move that reflects Medical Alley’s position as the global epicenter of health innovation and care, the Medical...
Collective Medical Introduces Enhanced Clinical Data Capabilities to Support Better Patient Outcomes
Collective partners with Kno2 to enable physician and care team members with high-value clinical insights at the point of care...
International Cannabrands Announces New Appointment to Management Team
LOS ANGELES, CA / ACCESSWIRE / November 18, 2019 / International Cannabrands Inc. (CSE:INCB) (the "Company") is pleased to announce...
SurfCT And Pearl Brings Artificial Intelligence To Dentistry
The fear that dental professionals may be replaced by robots is as real as the excitement of wondering what the...
Hemogenyx Pharmaceuticals PLC Announces Operational Update
Operational Update LONDON, UK / ACCESSWIRE / November 18, 2019 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new...
Genentech to Present New and Updated Data for Seven Approved and Investigational Medicines Across Multiple Types of Breast Cancer at the 2019 San Antonio Breast Cancer Symposium
— Study results reflect advancements in HER2-positive, triple-negative, and hormone receptor-positive breast cancer — — Follow-up data from pivotal Phase...
MorphoSys Continues to Build Commercial Presence by Opening new U.S. Headoffice
PLANEGG/MUNICH, GERMANY and BOSTON MA / ACCESSWIRE / November 15, 2019 / MorphoSys (FSE: MOR; Prime Standard Segment; MDAX & TecDAX;...
CORRECTION: AIM ImmunoTech Provides Business Update for the Third Quarter of 2019
This press release replaces the press release issued 11/15/2019 at 6:30 a.m., which included an incorrect date. The company had...
Humanigen to Present at the 2019 Stifel Healthcare Conference
BURLINGAME, CA / ACCESSWIRE / November 15, 2019 / Humanigen, Inc., (OTCQB:HGEN) ("Humanigen"), a clinical stage biopharmaceutical company focused on...
Applied BioSciences Reports Second Quarter Fiscal Year 2020 Financial Results and Outlines Corporate Strategy
Successfully building BioPharma pipeline in high-value indications Company plans to advance IND-cleared program into a Phase 1 study in a...
Heat Biologics Reports Third Quarter 2019 Results and Provides Corporate Update
Reported Positive Phase 2 Interim Data in Advanced Non-Small Cell Lung Cancer Patients MORRISVILLE, NC / ACCESSWIRE / November 15,...